On December 8, 2011, the U.S. Tax Court held that a whistleblower filing under 7623(b) of the IRS whistleblower provisions was entitled to remain anonymous in the case record to protect against retaliation and professional ostracism. In the landmark decision of Whistleblower 14106-10W v. Commissioner, 137 T.C. No. 15 (T.C.
Diakon Lutheran Social Ministries, a charitable organization operating as Diakon Hospice St. John (Diakon), agreed to pay the U.S. $10.56 million to settle allegations that it submitted claims for Medicare reimbursement for ineligible hospice patients from October 1, 2004 to October 1, 2010.
KV Pharmaceutical Company, the St. Louis parent corporation of the now defunct Ethex Corporation, has agreed to pay $17 million to the federal and state governments to resolve allegations that Ethex fraudulently received reimbursement for two of its drugs from federal healthcare programs. According to allegations made by relator Constance Conrad in U.S.
In an excellent op-ed piece written for the Lehigh Valley’s Morning Call, David Williams of Kline & Specter describes why Pennsylvania needs a False Claims Act to combat fraud against the state. Citing a 2005 study by the Pennsylvania attorney general’s office, Williams notes that fraudulent activities have consumed more than ten percent of Pennsylvania’s healthcare costs.
Merck has agreed to plead guilty to a misdemeanor criminal charge and pay $950 million to the federal and state governments to resolve allegations that it illegally marketed its painkiller drug Vioxx for off-label use and made false statements about the drug’s cardiovascular risks.
Marilyn Tavenner, the new administrator of the Center for Medicare and Medicaid Services (CMS), has drawn the support of major medical organizations including the American Medical Association (AMA), the American Hospital Association (AHA), America’s Health Insurance Providers (AHIP), and the Association of American Medical Colleges (AAMC). Tavenner was nominated by President Obama to be administrator of CMS after the resignation of Dr.
New York City has agreed to pay the federal government $70 million to settle claims that it allegedly overbilled Medicaid by improperly approving home care for elderly clients.
GlaxoSmithKline, one of the world’s largest drug manufacturers, settled a number of claims resulting from government investigations including one tied to the sale of diabetes drug, Avandia, which has been associated with increased heart risks, and one related to off-label marketing of other drug products.
An article authored by Marc S. Raspanti, Esquire and Bryan S. Neft, Esquire and published in The Legal Intelligencer, November 1, 2011.
To read the article see: https://www.falseclaimsact.com/wp-content/uploads/2013/02/20111101093225001.
DFine, a California provider of vertebral augmentation devices, agreed to resolve Justice Department allegations of false claims for $2.9 million. The government charged DFine with using customer surveys as vehicles to pay participating physicians kickbacks to induce them to use DFine devices.
If you are aware of any person, corporation or entity that you think may be violating the False Claims Act, securities, commodities, tax, anti-money laundering, or sanctions laws, contact us today.